168 related articles for article (PubMed ID: 9367352)
1. The amino-terminal fragment of human urokinase directs a recombinant chimeric toxin to target cells: internalization is toxin mediated.
Fabbrini MS; Carpani D; Bello-Rivero I; Soria MR
FASEB J; 1997 Nov; 11(13):1169-76. PubMed ID: 9367352
[TBL] [Abstract][Full Text] [Related]
2. Endocytosis of a chimera between human pro-urokinase and the plant toxin saporin: an unusual internalization mechanism.
Ippoliti R; Lendaro E; Benedetti PA; Torrisi MR; Belleudi F; Carpani D; Soria MR; Fabbrini MS
FASEB J; 2000 Jul; 14(10):1335-44. PubMed ID: 10877826
[TBL] [Abstract][Full Text] [Related]
3. A conjugate between human urokinase and saporin, a type-1 ribosome-inactivating protein, is selectively cytotoxic to urokinase receptor-expressing cells.
Cavallaro U; del Vecchio A; Lappi DA; Soria MR
J Biol Chem; 1993 Nov; 268(31):23186-90. PubMed ID: 8226837
[TBL] [Abstract][Full Text] [Related]
4. The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP.
Zuppone S; Assalini C; Minici C; Bertagnoli S; Branduardi P; Degano M; Fabbrini MS; Montorsi F; Salonia A; Vago R
Sci Rep; 2020 Feb; 10(1):2521. PubMed ID: 32054892
[TBL] [Abstract][Full Text] [Related]
5. Optimization of construct design and fermentation strategy for the production of bioactive ATF-SAP, a saporin based anti-tumoral uPAR-targeted chimera.
Errico Provenzano A; Posteri R; Giansanti F; Angelucci F; Flavell SU; Flavell DJ; Fabbrini MS; Porro D; Ippoliti R; Ceriotti A; Branduardi P; Vago R
Microb Cell Fact; 2016 Nov; 15(1):194. PubMed ID: 27842546
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity of ribosome-inactivating protein saporin is not mediated through alpha2-macroglobulin receptor.
Bagga S; Hosur MV; Batra JK
FEBS Lett; 2003 Apr; 541(1-3):16-20. PubMed ID: 12706812
[TBL] [Abstract][Full Text] [Related]
7. Pichia pastoris as a host for secretion of toxic saporin chimeras.
Lombardi A; Bursomanno S; Lopardo T; Traini R; Colombatti M; Ippoliti R; Flavell DJ; Flavell SU; Ceriotti A; Fabbrini MS
FASEB J; 2010 Jan; 24(1):253-65. PubMed ID: 19786581
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a saporin isoform with lower ribosome-inhibiting activity.
Fabbrini MS; Rappocciolo E; Carpani D; Solinas M; Valsasina B; Breme U; Cavallaro U; Nykjaer A; Rovida E; Legname G; Soria MR
Biochem J; 1997 Mar; 322 ( Pt 3)(Pt 3):719-27. PubMed ID: 9148741
[TBL] [Abstract][Full Text] [Related]
9. Targeting plant toxins to the urokinase and alpha 2-macroglobulin receptors.
Cavallaro U; Soria MR
Semin Cancer Biol; 1995 Oct; 6(5):269-78. PubMed ID: 8562904
[TBL] [Abstract][Full Text] [Related]
10. Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis.
Stirpe F; Derenzini M; Barbieri L; Farabegoli F; Brown AN; Knowles PP; Thorpe PE
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(5):259-71. PubMed ID: 2889289
[TBL] [Abstract][Full Text] [Related]
11. PMA-induced down-regulation of the receptor for alpha 2-macroglobulin in human U937 cells.
Conese M; Cavallaro U; Sidenius N; Olson D; Soria MR; Blasi F
FEBS Lett; 1995 Jan; 358(1):73-8. PubMed ID: 7821434
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells.
Fabbrini MS; Carpani D; Soria MR; Ceriotti A
FASEB J; 2000 Feb; 14(2):391-8. PubMed ID: 10657995
[TBL] [Abstract][Full Text] [Related]
13. Recombinant toxins that bind to the urokinase receptor are cytotoxic without requiring binding to the alpha(2)-macroglobulin receptor.
Rajagopal V; Kreitman RJ
J Biol Chem; 2000 Mar; 275(11):7566-73. PubMed ID: 10713063
[TBL] [Abstract][Full Text] [Related]
14. Biological and chemical characterization of basic FGF-saporin mitotoxin.
Lappi DA; Martineau D; Baird A
Biochem Biophys Res Commun; 1989 Apr; 160(2):917-23. PubMed ID: 2541718
[TBL] [Abstract][Full Text] [Related]
15. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Rosenblum MG; Marks JW; Cheung LH
Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
17. Expression of the human urokinase-type plasminogen activator receptor in E. coli and Chinese hamster ovary cells: purification of the recombinant proteins and generation of polyclonal antibodies in chicken.
Magdolen V; Rettenberger P; Lopens A; Oi H; Lottspeich F; Kellermann J; Creutzburg S; Goretzki L; Weidle UH; Wilhelm O
Electrophoresis; 1995 May; 16(5):813-6. PubMed ID: 7588568
[TBL] [Abstract][Full Text] [Related]
18. Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme.
Rustamzadeh E; Li C; Doumbia S; Hall WA; Vallera DA
J Neurooncol; 2003 Oct; 65(1):63-75. PubMed ID: 14649886
[TBL] [Abstract][Full Text] [Related]
19. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
20. Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae).
Ferreras JM; Barbieri L; Girbés T; Battelli MG; Rojo MA; Arias FJ; Rocher MA; Soriano F; Mendéz E; Stirpe F
Biochim Biophys Acta; 1993 Oct; 1216(1):31-42. PubMed ID: 8218413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
